(Updates prices)
* TSX down 39.63 points, or 0.29 percent, to 13,519.38
* Seven of the TSX's 10 main groups fall
TORONTO, Nov 6 (Reuters) - Canada's main stock index
retreated on Friday, as oil and mining company stocks dragged,
offsetting solid gains for financials.
Global oil prices slid, dragging the influential energy
sector lower, and gold miners were hit by a fall in the price of
bullion to a three-month low after the spike in U.S. employment
made it more likely the U.S. Federal Reserve will hike interest
rates in December.
Goldcorp Inc G.TO fell 4.1 percent to C$15.34, while
Barrick Gold Corp ABX.TO lost 4.6 percent to C$9.25.
The prospect of higher U.S. interest rates bolstered the
dollar, making commodities denominated in the greenback less
affordable to holders of other currencies.
At 11:19 a.m. ET (1619 GMT), the Toronto Stock Exchange's
S&P/TSX composite index .GSPTSE fell 39.63 points, or 0.29
percent, to 13,519.15.
Seven of the TSX's 10 main groups fell, with losses among
energy and mining stocks weighing most heavily on the index. The
overall energy group retreated 1.6 percent while the materials
group retreated 2.3 percent.
Pipeline company Enbridge Inc ENB.TO fell 2.3 percent to
C$51.69 while rival TransCanada Corp TRP.TO lost 2.5 percent
to C$44.13.
Enbridge said on Thursday that a delay in starting up a
pipeline to transport crude from Ontario to Quebec will hurt its
adjusted earnings for the year. urn:newsml:reuters.com:*:nL3N1304NG
Crude oil CLc1 prices were down 2.0 percent to $44.30 a
barrel, while Brent crude LCOc1 lost 1.3 percent to
$47.37. O/R
Gold futures GCc1 fell 1.4 percent to $1,089.5 an ounce,
while copper prices CMCU3 declined 0.4 percent to $4,993.5 a
tonne. GOL/ MET/L
Financials rose 0.8 percent, after the firm U.S. and
Canadian jobs data pointed to stronger growth, but also higher
interest rates, with the Canadian jobs gain suggesting that the
Bank of Canada can refrain from further easing. ECONCA
Sierra Wireless Inc SW.TO slumped 23.1 percent to C$25.37
after its earnings missed analyst expectations.
Valeant Pharmaceuticals International Inc (N:VRX) VRX.TO rallied
3.6 percent to C$107.11 after plunging as much as 20 percent
during Thursday's session. The company said on Friday that
Goldman Sachs (N:GS) sold 1.3 million shares of Valeant on Nov. 5 that
were securing loans made to its CEO Michael Pearson (L:PSON).
urn:newsml:reuters.com:*:nL1N1310Y6